State Street Corp 10x Genomics, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, State Street Corp holds 1,812,201 shares of TXG stock, worth $21.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,812,201

Previous 1,774,992 2.1%

Holding current value

$21.6 Million

Previous $25.5 Million 37.93%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$8.73 - $16.31 $324,834 - $606,878	37,209 Added 2.1%	1,812,201 $15.8 Million
Q4 2024 Feb 14, 2025	BUY	$13.18 - $21.31 $320,919 - $518,877	24,349 Added 1.39%	1,774,992 $25.5 Million
Q3 2024 Nov 14, 2024	BUY	$15.71 - $23.49 $1.83 Million - $2.74 Million	116,534 Added 7.13%	1,750,643 $39.5 Million
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $941,516 - $1.81 Million	48,407 Added 3.05%	1,634,109 $31.8 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $955,181 - $1.44 Million	26,474 Added 1.7%	1,585,702 $59.5 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $3.38 Million - $5.67 Million	98,591 Added 6.75%	1,559,228 $87.3 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $1.15 Million - $1.77 Million	28,100 Added 1.96%	1,460,637 $60.3 Million
Q2 2023 Aug 14, 2023	BUY	$50.96 - $58.72 $1.03 Million - $1.19 Million	20,190 Added 1.43%	1,432,537 $80 Million
Q1 2023 May 15, 2023	BUY	$35.33 - $55.79 $2.35 Million - $3.72 Million	66,598 Added 4.95%	1,412,347 $78.8 Million
Q4 2022 Feb 14, 2023	SELL	$24.4 - $41.3 $443,299 - $750,338	-18,168 Reduced 1.33%	1,345,749 $49 Million
Q3 2022 Nov 15, 2022	BUY	$28.48 - $52.59 $760,273 - $1.4 Million	26,695 Added 2.0%	1,363,917 $38.8 Million
Q2 2022 Aug 15, 2022	SELL	$36.95 - $82.41 $12.8 Million - $28.5 Million	-345,543 Reduced 20.53%	1,337,222 $60.5 Million
Q1 2022 May 16, 2022	BUY	$55.7 - $145.79 $910,305 - $2.38 Million	16,343 Added 0.98%	1,682,765 $128 Million
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $163,950 - $221,664	-1,214 Reduced 0.07%	1,666,422 $248 Million
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $10.7 Million - $14.1 Million	73,616 Added 4.62%	1,667,636 $243 Million
Q2 2021 Aug 16, 2021	BUY	$134.22 - $202.37 $62.2 Million - $93.8 Million	463,597 Added 41.01%	1,594,020 $312 Million
Q1 2021 May 17, 2021	BUY	$140.25 - $196.86 $8.26 Million - $11.6 Million	58,876 Added 5.49%	1,130,423 $205 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $64.3 Million - $83.2 Million	508,153 Added 90.19%	1,071,547 $152 Million
Q3 2020 Nov 10, 2020	BUY	$87.44 - $125.0 $6.24 Million - $8.93 Million	71,404 Added 14.51%	563,394 $70.2 Million
Q2 2020 Aug 14, 2020	BUY	$58.39 - $89.31 $28.3 Million - $43.3 Million	484,890 Added 6829.44%	491,990 $43.9 Million
Q1 2020 May 11, 2020	BUY	$51.57 - $106.62 $366,147 - $757,002	7,100 New	7,100 $442,000

Others Institutions Holding TXG

# of Institutions

305

Shares Held

109M

Call Options Held

228K

Put Options Held

157K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.13B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp 10x Genomics, Inc. Transaction History